These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The significance of leukotrienes in pathophysiology of bronchial asthma--therapy perspectives]. Wojnowski P; Patkowski J Postepy Hig Med Dosw; 1997; 51(5):499-514. PubMed ID: 9489451 [TBL] [Abstract][Full Text] [Related]
4. [Physiopathology of asthma: what role for leukotrienes?]. Lockhart A; Dinh-Xuan AT Rev Pneumol Clin; 1997; 53(3):119-27. PubMed ID: 9296112 [TBL] [Abstract][Full Text] [Related]
6. Development of novel anti-inflammatory agents: a pharmacologic perspective on leukotrienes and their receptors. Jackson WT; Fleisch JH Prog Drug Res; 1996; 46():115-68. PubMed ID: 8754204 [No Abstract] [Full Text] [Related]
7. Role of leukotrienes in coronary artery surgery. Allen SP; Yacoub MH Curr Opin Cardiol; 1995 Nov; 10(6):605-13. PubMed ID: 8573981 [TBL] [Abstract][Full Text] [Related]
8. Leukotrienes and atherosclerosis: new roles for old mediators. Jala VR; Haribabu B Trends Immunol; 2004 Jun; 25(6):315-22. PubMed ID: 15145321 [TBL] [Abstract][Full Text] [Related]
9. [The role of cysteinyl leukotrienes in chronic inflammation and neoplasia of the intestine]. Broom OJ; Nielsen OH Ugeskr Laeger; 2009 Jan; 171(4):243-6. PubMed ID: 19174041 [TBL] [Abstract][Full Text] [Related]
10. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle. Jonsson EW Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121 [TBL] [Abstract][Full Text] [Related]
11. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Singh RK; Gupta S; Dastidar S; Ray A Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735 [TBL] [Abstract][Full Text] [Related]
12. [Leukotrienes and asthma. Clinical and experimental experiences with leukotriene receptor antagonists and leukotriene synthesis inhibitors]. Henriksen AH; Bjermer L Tidsskr Nor Laegeforen; 1997 Feb; 117(5):647-51. PubMed ID: 9102953 [TBL] [Abstract][Full Text] [Related]
13. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets? Sharma JN; Mohammed LA Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707 [TBL] [Abstract][Full Text] [Related]
14. [Roles of leukotrienes in immunological and allergic disorders]. Yokomizo T Nihon Rinsho; 2005 May; 63 Suppl 5():47-52. PubMed ID: 15954323 [No Abstract] [Full Text] [Related]
15. Leukotrienes and atherosclerosis. Khan Z; Tripathi CD Indian Heart J; 2005; 57(2):175-80. PubMed ID: 16013362 [No Abstract] [Full Text] [Related]
16. Leukotriene receptors. Nakamura M; Shimizu T Chem Rev; 2011 Oct; 111(10):6231-98. PubMed ID: 21526749 [No Abstract] [Full Text] [Related]
17. International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions. Bäck M; Dahlén SE; Drazen JM; Evans JF; Serhan CN; Shimizu T; Yokomizo T; Rovati GE Pharmacol Rev; 2011 Sep; 63(3):539-84. PubMed ID: 21771892 [TBL] [Abstract][Full Text] [Related]
18. Leukotrienes: lipid bioeffectors of inflammatory reactions. Sala A; Zarini S; Bolla M Biochemistry (Mosc); 1998 Jan; 63(1):84-92. PubMed ID: 9526099 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells. Thivierge M; Stankova J; Rola-Pleszczynski M J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346 [TBL] [Abstract][Full Text] [Related]
20. Treatment of asthma with drugs modifying the leukotriene pathway. Drazen JM; Israel E; O'Byrne PM N Engl J Med; 1999 Jan; 340(3):197-206. PubMed ID: 9895400 [No Abstract] [Full Text] [Related] [Next] [New Search]